103 related articles for article (PubMed ID: 1728362)
21. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.
Goodson WH; Moore DH; Ljung BM; Chew K; Mayall B; Smith HS; Waldman FM
Breast Cancer Res Treat; 2000 Jan; 59(2):113-23. PubMed ID: 10817346
[TBL] [Abstract][Full Text] [Related]
24. Proliferative activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labeling.
Kamata T; Yonemura Y; Sugiyama K; Ooyama S; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer; 1989 Oct; 64(8):1665-8. PubMed ID: 2790680
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
Gasińska A; Krzyszk wski T; Niemiec J; Adamczyk A; Skołyszewski J
Folia Histochem Cytobiol; 2000; 38(4):175-80. PubMed ID: 11185722
[TBL] [Abstract][Full Text] [Related]
26. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of DNA ploidy and proliferating cell nuclear antigen in gastric cancer.
Hirose K; Iida A; Yamaguchi A; Onchi H; Awata H; Katayama K; Nakagawara G
Oncology; 1998; 55(4):300-6. PubMed ID: 9663419
[TBL] [Abstract][Full Text] [Related]
28. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
[TBL] [Abstract][Full Text] [Related]
29. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
30. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
31. DNA ploidy is a major prognostic factor in advanced gastric carcinoma--univariate and multivariate analysis.
Haraguchi M; Watanabe A; Moriguchi S; Korenaga D; Maehara Y; Okamura T; Sugimachi K
Surgery; 1991 Nov; 110(5):814-9. PubMed ID: 1948649
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study on the cell kinetics of gastric cancer using bromodeoxyuridine labeling index--its relations with DNA ploidy pattern and epidermal growth factor].
Tsushima H
Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):41-9. PubMed ID: 8437551
[TBL] [Abstract][Full Text] [Related]
33. [Fluorocytometric DNA analysis of intestinal metaplasia associated with gastric carcinoma].
Oshiro T; Baba H; Okuyama T; Inutsuka S; Takeuchi H; Adachi Y; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1993 Apr; 20(6):709-12. PubMed ID: 8489271
[TBL] [Abstract][Full Text] [Related]
34. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of DNA content in gastric and colorectal cancer.
Chistyakova OV; Zubrikhina GN
Anal Quant Cytol Histol; 1998 Feb; 20(1):52-8. PubMed ID: 9513691
[TBL] [Abstract][Full Text] [Related]
36. Ploidy and proliferative activity of human gastric carcinoma: a cytofluorometric study on fresh and on paraffin embedded material.
Danova M; Mazzini G; Wilson G; Ucci G; Dionigi P; Riccardi A; Fiocca R
Basic Appl Histochem; 1987; 31(1):73-82. PubMed ID: 3593174
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic value of DNA ploidy in epithelial elevated lesions of the stomach].
Nakano O; Fujimaki E; Orii S; Chiba S; Yamashiki H; Fujino Y; Tazawa H; Sato K; Sato S; Sasaki K
Gan To Kagaku Ryoho; 1993 Apr; 20(6):804-7. PubMed ID: 8489289
[TBL] [Abstract][Full Text] [Related]
39. [A study of DNA heterogeneity on gastric cancer with serosal invasive exposure].
Tadaoka N; Aoki T; Hirai K; Tsukamoto T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():21-6. PubMed ID: 8203925
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
